ETF Sources:

• IBB iShares Nasdaq Biotechnology

• XLV S&P Healthcare Index  

• XBI SPDR S&P Biotech  

• XHS SPDR S&P Health Care Services

• XHE SPDR S&P Health Care Equipment

• IHF iShares U.S. Healthcare Providers

 

Nonspecific Screening Criteria:

• Market Cap:  >500M

• Share Price: >$2.00

• Beta: < 1.5

• IPO Date: >5 years

 

Revenue Generating Screeners:

• P/E: <50

• Dividend Yield: >2%

 

Screeners for non-revenue companies:

• Stage 2 or above on most promising pipeline candidate

• One compound in the pipeline must have FDA designation: breakthrough therapy, orphan drug, fast track, priority review, accelerated approval process